Related Experiment Video
Updated: Jun 7, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Dysbindin-1 modulates prefrontal cortical activity and schizophrenia-like behaviors via dopamine/D2 pathways
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, Bethesda, MD 20892, USA. francesco.papaleo@iit.it
Abstract:
Dysbindin-1 regulates D2-receptor trafficking and is implicated in schizophrenia and related cognitive abnormalities, but whether this molecular effect mediates the clinical manifestations of the disorder is unknown. We explored in dysbindin-1-deficient mice (dys-/-) (1) schizophrenia-related behaviors, (2) molecular and electrophysiological changes in medial prefrontal cortex (mPFC) and (3) the dependence of these on D2-receptor stimulation. Dysbindin-1 disruption altered dopamine-related behaviors and impaired working memory under challenging/stressful conditions. Dys-/- pyramidal neurons in mPFC layers II/III were hyperexcitable at baseline but hypoexcitable following D2 stimulation. Dys-/- were also respectively more and less sensitive to D2 agonist- and antagonist-induced behavioral effects. Dys-/- had reduced expression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and CaMKKβ in mPFC. Chronic D2 agonist treatment reproduced these changes in protein expression, and some of the dys-/- behavioral effects. These results elucidate dysbindin's modulation of D2-related behavior, cortical activity and mPFC CaMK components, implicating cellular and molecular mechanisms of the association of dysbindin with psychosis.
Insights
Dysbindin-1 deficiency in mice alters dopamine-related behaviors and impairs working memory, particularly under stress. This study reveals molecular and cellular changes in the medial prefrontal cortex linked to psychosis.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Dysbindin-1 is linked to schizophrenia and regulates dopamine D2-receptor trafficking.
- The precise molecular mechanisms connecting dysbindin-1 to schizophrenia's clinical symptoms remain unclear.
Purpose of the Study:
- To investigate the role of dysbindin-1 in schizophrenia-related behaviors, medial prefrontal cortex (mPFC) function, and D2-receptor signaling in mice.
- To explore how dysbindin-1 deficiency affects neural excitability and molecular pathways in the mPFC.
Main Methods:
- Utilized dysbindin-1-deficient mice (dys-/-) to assess behavioral phenotypes.
- Examined molecular and electrophysiological changes in the mPFC.
- Investigated the impact of D2-receptor stimulation on behavior and neural activity.
Main Results:
- Dysbindin-1 disruption altered dopamine-related behaviors and impaired working memory under stress.
- Pyramidal neurons in the mPFC of dys-/- mice showed altered excitability.
- Reduced expression of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) and CaMKKβ was observed in the mPFC of dys-/- mice.
- D2-receptor agonist treatment mimicked some molecular and behavioral effects.
Conclusions:
- Dysbindin-1 modulates D2-receptor-related behaviors and cortical activity.
- Cellular and molecular changes in the mPFC, including CaMK pathways, are implicated in the association between dysbindin-1 and psychosis.
- Findings provide insights into the neurobiological underpinnings of schizophrenia.
More Related Videos
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Drugs Affecting Neurotransmitter Synthesis
Neural Regulation
Parkinson Disease ll: Pathophysiology